← Leaderboards
Angelika Niemz
California Institute Of Technology
$6,411,588
Attributed
$12,015,671
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2006–19$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$12,015,671 · 7
By mechanism
R01$8,162,612 · 3
R44$3,000,000 · 1
R21$797,255 · 2
F32$55,804 · 1
Top collaborators
- Robert William Doebler7 shared
- James D Sterling5 shared
- Karl Voelkerding5 shared
- Gerard A Cangelosi4 shared
- Masa Narita4 shared
- David Scott Boyle3 shared
- Tanya Marie Ferguson2 shared
- Brenda Elaine Jones2 shared
Most similar at California Institute Of Technology
Same institution · by research overlap
- Stephen R Quake$23,934,342
- Mikhail Shapiro$21,032,002
- James R. Heath$23,260,811
- David Baltimore$19,087,119
- Steven Low$5,012,590
Others in their field
Top investigators on “Point Of Care”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- David Heimbrook · Leidos Biomedical Research, Inc.$122,677,088
- Judith S Hochman · New York University School Of Medicine$101,773,796
- Michael S. Saag · University Of Alabama At Birmingham$85,103,222
- Constance Ann Benson · University Of California, San Diego$66,071,396
- Mark Marino · Venturewell$61,796,923
Research focus
Point Of CareBaseSamplingDetectionPreparationDevicesCytolysisReagentDiagnosisCostDiagnosticDesignPrototypeCoupledPathogenLateralResourcesNucleic Acid Amplification TestsSensitivity And SpecificityDna AmplificationBiothreatComplexEngineeringLaboratories
Grant awards (22)
Integrated Point of Care Nucleic Acid Testing for Acute Dengue Virus Infection$171,896
R21 · FY2019 · AI · contact PI
Integrated Point of Care Nucleic Acid Testing for Acute Dengue Virus Infection$222,112
R21 · FY2018 · AI · contact PI
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis$538,394
R01 · FY2017 · AI · contact PI
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis$541,354
R01 · FY2016 · AI · contact PI
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis$555,804
R01 · FY2015 · AI · contact PI
A fully integrated assay and platform for detecting Clostridium difficile.$1,000,000
R44 · FY2014 · AI
Integrated Cost-Effective Point of Care Nucleic Acid Testing for TB diagnosis$607,711
R01 · FY2014 · AI · contact PI
A fully integrated assay and platform for detecting Clostridium difficile.$1,000,000
R44 · FY2013 · AI
Rapid Diagnosis of MDR TB from Sputum using a Small Fully Integrated Nucleic Acid$803,134
R01 · FY2013 · AI · contact PI
A fully integrated assay and platform for detecting Clostridium difficile.$1,000,000
R44 · FY2012 · AI
Rapid Diagnosis of MDR TB from Sputum using a Small Fully Integrated Nucleic Acid$841,972
R01 · FY2012 · AI · contact PI
Rapid Diagnosis of MDR TB from Sputum using a Small Fully Integrated Nucleic Acid$846,903
R01 · FY2011 · AI · contact PI
Rapid Isothermal Nucleic Acid Amplification Assay and Device for HSV Testing$539,248
R01 · FY2011 · AI · contact PI
Rapid Diagnosis of MDR TB from Sputum using a Small Fully Integrated Nucleic Acid$1,007,150
R01 · FY2010 · AI · contact PI
Rapid Isothermal Nucleic Acid Amplification Assay and Device for HSV Testing$547,185
R01 · FY2010 · AI · contact PI
Rapid Isothermal Nucleic Acid Amplification Assay and Device for HSV Testing$153,336
R01 · FY2010 · AI · contact PI
Rapid Isothermal Nucleic Acid Amplification Assay and Device for HSV Testing$573,692
R01 · FY2009 · AI · contact PI
Rapid Isothermal Nucleic Acid Amplification Assay and Device for HSV Testing$606,729
R01 · FY2008 · AI · contact PI
Isothermal Colorimetric Pathogen DNA Diagnostics$217,316
R21 · FY2007 · AI · contact PI
Isothermal Colorimetric Pathogen DNA Diagnostics$185,931
R21 · FY2006 · AI · contact PI
ORIENTED PROTEIN ARRAYS ON POLYMERS NANOSTRUCTURES$24,888
F32 · FY2001 · GM
ORIENTED PROTEIN ARRAYS ON POLYMERS NANOSTRUCTURES$30,916
F32 · FY2000 · GM